TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Chiron Pharmasynth AS
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
15,368
|
15,135
|
10,392 |
| Financial expenses |
1
|
200
|
88 |
| Earnings before taxes |
-162
|
3,360
|
1,337 |
| Total assets |
20,129
|
21,834
|
20,104 |
| Current assets |
20,129
|
21,834
|
20,104 |
| Current liabilities |
8,252
|
9,158
|
7,686 |
| Equity capital |
11,877
|
12,676
|
12,418 |
| - share capital |
1,118
|
1,177
|
1,254 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
59.0%
|
58.1%
|
61.8% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-1.1%
|
22.2%
|
12.9% |
| Return on assets (ROA) |
-0.8%
|
16.3%
|
7.1% |
| Current ratio |
243.9%
|
238.4%
|
261.6% |
| Return on equity (ROE) |
-1.4%
|
26.5%
|
10.8% |
| Change turnover |
992
|
5,382
|
3,811 |
| Change turnover % |
7%
|
55%
|
58% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.